SCHEMBL14870925

SCHEMBL14870925

CCOC(=O)C1CCC[C@@H]1C1CCC(Br)CC1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.34
PPM1B O75688 1/20 0.33
PTPN1 P18031 1/20 0.33
PPP1CC P36873 1/20 0.33
CA12 O43570 2/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
TLR4 O00206 1/20 0.33
CA9 Q16790 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 2/20 0.33
TP53 P04637 1/20 0.33
CYP3A4 P08684 1/20 0.33
TSHR P16473 2/20 0.32
GAA P10253 1/20 0.32
KMT2A Q03164 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
PKM P14618 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15800134 1.00 ALDH1A1 (0.34) ALDH1A1PPM1BPTPN1PPP1CCCA12
SCHEMBL7733838 0.87 ALDH1A1 (0.41) ALDH1A1PPM1BPTPN1PPP1CCTLR4
SCHEMBL3003560 0.87 ALDH1A1 (0.41) ALDH1A1PPM1BPTPN1PPP1CCTLR4
SCHEMBL31017143 0.87 ALDH1A1 (0.37) ALDH1A1PPM1BPTPN1PPP1CCCA12
SCHEMBL417314 0.87 ALDH1A1 (0.37) ALDH1A1PPM1BPTPN1PPP1CCCA12
SCHEMBL14870941 0.85 ALDH1A1 (0.43) ALDH1A1PPM1BPTPN1PPP1CCMAPT
SCHEMBL15800125 0.80 ALDH1A1 (0.36) ALDH1A1PPM1BPTPN1PPP1CCCA12
SCHEMBL594647 0.77 TP53 (0.48) ALDH1A1PPM1BPTPN1PPP1CCTLR4
SCHEMBL594645 0.77 TP53 (0.48) ALDH1A1PPM1BPTPN1PPP1CCTLR4
SCHEMBL6899600 0.77 TP53 (0.48) ALDH1A1PPM1BPTPN1PPP1CCTLR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130096338-A1 ASYMMETRIC CYCLIZATION PROCESSES USING UNSATURATED NITRO COMPOUNDS NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2013-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130096338-A1 ASYMMETRIC CYCLIZATION PROCESSES USING UNSATURATED NITRO COMPOUNDS NQO1, COASY, NOS2 ALDH1A1 2383/4885PPM1B 4181/4885PTPN1 4454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.